Format

Send to

Choose Destination
J Neuroimmunol. 2012 Nov 15;252(1-2):75-82. doi: 10.1016/j.jneuroim.2012.07.013. Epub 2012 Aug 20.

Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank.

Author information

1
Department of Clinical Biochemistry and Immunology, Statens Serum Institute, Ørestads Boulevard 5/84, Copenhagen S 2300, Denmark. morsi.abdallah@med.uni-rostock.de

Abstract

The aim of the study was to analyze cytokine profiles in neonatal dried blood samples (n-DBSS) retrieved from The Danish Newborn Screening Biobank of children developing Autism Spectrum Disorders (ASD) later in life and controls. Samples of 359 ASD cases and 741 controls were analyzed using Luminex xMAP technology and clinical data were retrieved from nationwide registers. Findings showed that children developing ASD were more likely to have decreased levels of both T helper-1(Th-1)-like cytokines (i.e. IFN-γ) and Th-2like cytokines (i.e. IL-4, IL-10) which may suggest a depressed or hypoactive immune cell activity during neonatal period in ASD.

PMID:
22917523
DOI:
10.1016/j.jneuroim.2012.07.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center